CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to EVMN

EVO756, Dose 1

Phase 2
Evommune, Inc. (EVMN)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '27
EVMNPhase 2

EVO756, Dose 1 Phase 2 Est. Readout

EVO756, Dose 1
Oct 2027~
CT.gov
00%
Drug Information

Target Indication

Migraine

Clinical Trial

NCT07616128

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.